143 related articles for article (PubMed ID: 32494772)
1. Randomized trial to evaluate contraceptive efficacy, safety and acceptability of a two-rod contraceptive implant over 4 years in the Dominican Republic.
Steiner MJ; Brache V; Taylor D; Callahan R; Halpern V; Jorge A; Wevill S; Sergison J; Venkatasubramanian L; Dorflinger L
Contracept X; 2019; 1():100006. PubMed ID: 32494772
[TBL] [Abstract][Full Text] [Related]
2. Levonorgestrel release rates measured through analysis of two-rod contraceptive explants.
Fuchs R; Taylor D; Jenkins DW; Brache V; Luo D; Dorflinger LJ; Steiner MJ
Contracept X; 2020; 2():100039. PubMed ID: 32995746
[TBL] [Abstract][Full Text] [Related]
3. Cohort study to evaluate efficacy, safety and acceptability of a two-rod contraceptive implant during third, fourth and fifth year of product use in China.
Che Y; Taylor D; Luo D; Maldonado LY; Wang M; Wevill S; Vahdat H; Han X; Halpern V; Dorflinger L; Steiner MJ
Contracept X; 2019; 1():100008. PubMed ID: 32494773
[TBL] [Abstract][Full Text] [Related]
4. In vivo release of levonorgestrel from Sino-implant (II) — an innovative comparison of explant data.
Callahan RL; Taylor D; Jenkins DW; Owen DH; Cheng L; Cancel AM; Dorflinger LJ; Steiner MJ
Contraception; 2015 Oct; 92(4):350-5. PubMed ID: 26142619
[TBL] [Abstract][Full Text] [Related]
5. Sino-implant (II)--a levonorgestrel-releasing two-rod implant: systematic review of the randomized controlled trials.
Steiner MJ; Lopez LM; Grimes DA; Cheng L; Shelton J; Trussell J; Farley TM; Dorflinger L
Contraception; 2010 Mar; 81(3):197-201. PubMed ID: 20159174
[TBL] [Abstract][Full Text] [Related]
6. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness, safety and acceptability of Sino-implant (II) during the first year of use: results from Kenya and Pakistan.
Lendvay A; Otieno-Masaba R; Azmat SK; Wheeless A; Hameed W; Shaikh BT; Kuria S; Steiner MJ; Chen M; Feldblum PJ
Contraception; 2014 Mar; 89(3):197-203. PubMed ID: 24439674
[TBL] [Abstract][Full Text] [Related]
8. Contraception with two levonorgestrel rod implants. A 5-year study in the United States and Dominican Republic.
Sivin I; Alvarez F; Mishell DR; Darney P; Wan L; Brache V; Lacarra M; Klaisle C; Stern J
Contraception; 1998 Nov; 58(5):275-82. PubMed ID: 9883382
[TBL] [Abstract][Full Text] [Related]
9. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
Ali M; Akin A; Bahamondes L; Brache V; Habib N; Landoulsi S; Hubacher D;
Hum Reprod; 2016 Nov; 31(11):2491-2498. PubMed ID: 27671673
[TBL] [Abstract][Full Text] [Related]
10. Removal of a well-palpable one-rod subdermal contraceptive implant using a dedicated hand-held device or standard technique: a randomized, open-label, non-inferiority trial.
Hubacher D; Byamugisha J; Kakaire O; Nalubwama H; Emtell Iwarsson K; Bratlie M; Chen PL; Gemzell-Danielsson K
Hum Reprod; 2022 Sep; 37(10):2320-2333. PubMed ID: 35960174
[TBL] [Abstract][Full Text] [Related]
11. Implant removal experience with Sino-implant (II) at four Chinese sites.
Cheng L; Steiner MJ; Meng H; Luo D; Zhong Y; Cheng Y; Chen G; Ni H; Feldblum PJ
Contraception; 2014 Sep; 90(3):249-52. PubMed ID: 24965314
[TBL] [Abstract][Full Text] [Related]
12. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy.
Power J; French R; Cowan F
Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD001326. PubMed ID: 17636668
[TBL] [Abstract][Full Text] [Related]
13. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
[TBL] [Abstract][Full Text] [Related]
14. Subdermal contraceptive implants.
Peralta O; Diaz S; Croxatto H
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):223-6. PubMed ID: 7626459
[TBL] [Abstract][Full Text] [Related]
15. Transition from Norplant to Jadelle in a clinic with extensive experience providing contraceptive implants.
Brache V; Faundes A; Alvarez F; García AG
Contraception; 2006 Apr; 73(4):364-7. PubMed ID: 16531168
[TBL] [Abstract][Full Text] [Related]
16. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
17. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
Sivin I
Drug Saf; 2003; 26(5):303-35. PubMed ID: 12650633
[TBL] [Abstract][Full Text] [Related]
18. Experience of Thai women in Bangkok with Norplant-2 implants.
Chompootaweep S; Kochagarn E; Tang-Usaha J; Theppitaksak B; Dusitsin N
Contraception; 1998 Oct; 58(4):221-5. PubMed ID: 9866003
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Norplant implants among Thai women in Bangkok.
Chompootaweep S; Kochagarn E; Sirisumpan S; Tang-usaha J; Theppitaksak B; Dusitsin N
Contraception; 1996 Jan; 53(1):33-6. PubMed ID: 8631187
[TBL] [Abstract][Full Text] [Related]
20. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
Sivin I; Campodonico I; Kiriwat O; Holma P; Diaz S; Wan L; Biswas A; Viegas O; el din Abdalla K; Anant MP; Pavez M; Stern J
Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
